COL10A1 and gastric adenocarcinoma: Necula et al. (14) identified a significant increase in COL10A1 plasma level in patients with STAD and concluded that COL10A1 shows an elevated expression from the beginning of carcinogenesis, in the early stages, and its increased level remains elevated during gastric cancer progression.